Clinical Research at FKP

You could help us discover the future of medical care by volunteering to participate in a clinical research study. Join hundreds of other people helping to find new life-saving medical treatments. Will you help us? Inquire today!

What Are Clinical Trials?

Clinical trials, also called research studies, test new ways to prevent, detect, or treat diseases. Under the supervision of a medical doctor and other research professionals, individuals who participate in a clinical trial may receive investigational treatments with the goal of establishing the benefits of the treatment for the specific disease or condition. 

For kidney disease, these trials can explore new medications, treatments, or lifestyle changes that could improve your health and quality of life. By participating in a clinical trial, you play a crucial role in helping doctors and researchers develop better treatments for kidney disease.

Why are clinical trials important? 

Every day, countless individuals participate in clinical research studies. The medications you, your friends, and your family use – or have ever used – are accessible thanks to these crucial studies. Clinical research is essential to demonstrate that a medication or treatment is safe and effective. Such studies are only possible due to the willingness of participants. Their participation is irreplaceable, offering invaluable insights that aid doctors in achieving medical advancements.

Should I participate in a clinical trial? 

Deciding to participate in a clinical trial is a personal choice. It’s important to discuss with your doctor whether a trial is a good option for you. Consider the potential benefits, risks, and time commitments involved.

There are a number of reasons why people participate in a clinical study: 

  • High-Quality Care: Participants in clinical trials often receive close monitoring and care from leading healthcare professionals and researchers. Often, participating in a research study can offer treatment options that may otherwise be unavailable. 
  • Support for Patients: Clinical trials are designed with your safety in mind. All trials follow strict guidelines and are reviewed by experts to ensure they are safe and ethical.
  • Contribute to Science: Your participation can help advance medical research and improve treatments for kidney disease. This can help others who may face the same health challenges in the future.

What to Expect in a Clinical Trial

Screening: Before joining, you will go through a screening process to determine if you are eligible. This may include a review of your medical history and some tests.

Participation: If you qualify, you may receive the treatment being studied and will be regularly monitored by the research team. You may need to visit the clinic frequently for check-ups and tests.

Follow-Up: After the trial ends, you might have follow-up visits to check on your health and gather more information about the long-term effects of the treatment.

You can withdraw from a study at any time, even after you’ve agreed to participate. 

If you’re interested in learning more about clinical trials for kidney disease, talk to your healthcare provider or contact our office. Together, we can determine if there is a clinical trial that is right for you.

For more information about ongoing clinical trials and how to participate, please call or visit one of our office locations. If you are an existing patient, you can send us a message through the patient portal

By joining a clinical trial, you are contributing to the future of kidney disease treatment and helping to improve the lives of many patients. Thank you for considering this important opportunity.

  • Amgen- ANCA Vasculitis

    Target Patient Population:Patients with antineutrophilcytoplasmic autoantibody (ANCA)-associated vasculitis Study Overview: To Evaluate the long- term safety and efficacy of Avacopan in patients with Antineutrophil Cytoplasmic Antibody…

    Read More

  • Novartis-Lupus Nephritis

    Target Patient Population: Patients with Active Lupus Nephritis Class III-IV, +/- V Study Overview: Part 1: To determine whether Iptacopan (study drug)  in combination with…

    Read More

  • Vera- IgAN

    Target Patient Population:Patients with a diagnosis of IgAN who have persistent proteinuria who remain at high risk of disease progression despite being on a…

    Read More

  • Eli Lilly- Obesity with CKD or ASCVD

    Target Patient Population: Adults >45 years of age, with a body mass index (BMI) of ≥27 kg/m2 and heart related and/or kidney related disease Study…

    Read More

  • AstraZeneca BaxDuo- Resistant Hypertension with CKD

    Target Patient Population: Hypertension patients who are on an SGLT2 or will benefit from the addition of an SGLT2. Study Overview: Will determine whether baxdrostat/ dapagliflozin…

    Read More

  • Bayer- T2 Diabetes

    Target Patient Population: Patients with CKD and T2D Study Overview: To assess the efficacy and safety of finerenone plus empagliflozin compared with either finerenone or empagliflozin…

    Read More